Homepage
Catalog of Screening Compounds
Screening Libraries
Focused and Target Libraries
Active Reference Sets
Diversity Libraries
Screening Compounds
Building blocks
Drug Discovery Services
Custom Chemistry
Medicinal chemistry
In silico Drug Design (CADD)
Discovery Biology
Animal Models
Toxicology and Safety
ADME, DMPK
Chemistry, Manufacturing and Controls
Company
News & Media
Contact us
For suppliers
Trends in discovery compounds
Homepage
>
Company
>
Media
>
Pharma News
>
2017
Pharma News, 2017
Merck Gets Booster from Chinese HPV Vaccine Approval
(Beijing) – China’s drug regulators have approved the commercial sale of Merck & Co.
Gedeon Richter drug received positive opinion from CHMP
Gedeon Richter Plc announces that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion on the company’s app...
At last, an alternative to the flu jab? Scientists accidentally discover drug that could treat the virus and speed up recovery
A new flu drug could be used to treat the virus and speed up recovery, a new study claims.
FDA approves first cancer treatment for any solid tumor with a specific genetic feature
The U.
Regeneron and Sanofi Announce FDA Approval of Kevzara® (sarilumab) for the Treatment of Moderately to Severely Active Rheumatoid Arthritis in Adult Patients
Regeneron Pharmaceuticals, Inc.
Benralizumab Associated with Less Use of Oral Glucocorticoids in Severe Asthma
The investigational monoclonal antibody benralizumab is associated with reduced oral glucocorticoid use in patients with severe asthma, according to a phase 3, industry-funded trial published in the N...
Japan to bring forward target for increased generic drug use: sources
Japan will bring forward a target to boost the use of generic drugs by six months to September 2020, two government sources with direct knowledge of the matter said on Tuesday.
Nektar Therapeutics & Takeda Strike Research Parternship for Oncology Compounds
Nektar Therapeutics (NASDAQ.
Cancer Research UK funded scientists to test Zika virus on brain tumours
Scientists funded by Cancer Research UK will investigate the effectiveness of the Zika virus in destroying brain tumour cells, which could lead to new treatments for cancer.
Chicago startup snares $65M to combat drug-resistant superbugs
Iterum Therapeutics has raised $65 million in an oversubscribed Series B round of funding.
FDA approves hypertension generic
MUMBAI, India — Jubilant Life Sciences announced that Jubilant Pharma, a material wholly owned subsidiary of the company, through one of its wholly owned subsidiaries, has received Food and Drug Adm...
Dr. Reddy’s earns FDA approval for Doxil generic
PRINCETON, N.
42
43
44
45
46
47
48
49
50
